Acrylic Acid

Acrylic Acid

SCHEMBL215856

C=C(C)C(=O)OC.C=CC(=O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
LMNA P02545 1/20 0.48
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 6/20 0.40
HCAR2 Q8TDS4 2/20 0.36
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.33
EGLN1 Q9GZT9 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ELANE P08246 1/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL1945873 1.00 ALDH1A1 (0.71) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL9421225 1.00 ALDH1A1 (0.71) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL15463386 1.00 ALDH1A1 (0.71) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL9421234 1.00 ALDH1A1 (0.71) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL7214354 1.00 ALDH1A1 (0.71) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL28084300 0.98 ALDH1A1 (0.68) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL27960065 0.98 ALDH1A1 (0.68) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL8731587 0.98 ALDH1A1 (0.68) ALDH1A1LMNAALOX15HSD17B10TSHR
Acrylic Acid SCHEMBL29120232 0.98 ALDH1A1 (0.68) ALDH1A1LMNAALOX15HSD17B10TSHR
Methacrylic Acid SCHEMBL1947179 0.96 ALDH1A1 (0.65) ALDH1A1LMNAALOX15HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1082 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226080-A1 Pharmaceutical Mixture Comprising Amorphous Pitolisant TIEFENBACHER ALFRED E GMBH & CO KG (DE) 2024-07-11 US claimed
CN-118290820-A Preparation method and application of solid glass beads 万华化学(宁波)有限公司 2024-07-05 CN claimed
EP-4374854-A1 PHARMACEUTICAL MIXTURE COMPRISING AMORPHOUS PITOLISANT Alfred E. Tiefenbacher (GmbH & Co. KG) (DE) 2024-05-29 EP claimed
CN-118063844-A Polymer product, preparation method and application thereof 中国石油化工股份有限公司 2024-05-24 CN claimed
WO-2024039661-A1 PROCESSABLE POLYVINYL CHLORIDE COMPOUNDS GALATA CHEMICALS LLC (US) 2024-02-22 WO claimed
EP-4312994-A1 ORAL FORMULATION OF A PYRIDINONE DERIVATE AND USE THEREOF IN PROPHYLAXIS AND/OR TREATMENT OF INTESTINAL FIBROSIS Dr. Falk Pharma Gmbh (DE) 2024-02-07 EP claimed
CN-117460786-A Polycarbonate resin composition and molded article 出光兴产株式会社 2024-01-26 CN claimed
CN-116751396-A Cellulose nanocrystalline photonic film capable of self-healing and preparation method thereof 青岛科技大学 2023-09-15 CN claimed
CN-116710078-A Sentanafadine pharmaceutical formulations and methods of making and using same 大塚制药株式会社 2023-09-05 CN claimed
CN-116178868-A Thermoplastic resin composition and molded article comprising the same 现代自动车株式会社 2023-05-30 CN claimed
WO-1998032425-A1 PHARMACEUTICAL FORMULATIONS WITH DELAYED DRUG RELEASE POLI INDUSTRIA CHIMICA S.P.A. (US) 1998-07-30 WO claimed
EP-0132317-B1 THE USE OF DISPERSING AIDS IN PROCESSING AID COMPOSITIONS FOR VINYL CHLORIDE POLYMER, THE PRODUCTION OF SAID COMPOSITIONS AND VINYL CHLORIDE COMPOSITIONS CONTAINING THEM ROHM AND HAAS COMPANY (US) 1993-04-07 EP claimed
CN-1009015-B ELECTRICALLY CONDUCTIVE CARBON COATED FIBERS ARMSTRONG WORLD IND INC (US) 1990-08-01 CN claimed
CN-1030108-A ELECTRICALLY CONDUCTIVE CARBON COATED FIBERS ARMSTRONG WORLD IND INC (US) 1989-01-04 CN claimed
EP-0037686-B1 IMPACT MODIFIER COMPOSITIONS, THEIR PRODUCTION AND THERMOPLASTIC POLYMER COMPOSITIONS CONTAINING THEM ROHM AND HAAS COMPANY (US) 1988-06-01 EP claimed
US-4513111-A Process for producing impact-resistant resins MITSUBISHI RAYON CO., LTD. (JP) 1985-04-23 US claimed
EP-0132317-A1 The use of dispersing aids in processing aid compositions for vinyl chloride polymer, the production of said compositions and vinyl chloride compositions containing them ROHM AND HAAS COMPANY (US) 1985-01-30 EP claimed
US-4440905-A ELASTOMER AND GELATION INHIBITOR ROHM AND HAAS COMPANY (US) 1984-04-03 US claimed
EP-0037686-A2 Impact modifier compositions, their production and thermoplastic polymer compositions containing them ROHM AND HAAS COMPANY (US) 1981-10-14 EP claimed
US-4111870-A PRIMER COMPOSITION OF AN ACRYLIC EPOXY ESTER GRAFT COPOLYMER, A HIGH MOLECULAR WEIGHT EPOXY RESIN AND A HEAT REACTIVE CONDENSATE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-09-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226080-A1 Pharmaceutical Mixture Comprising Amorphous Pitolisant GABARAPL1, SLC6A11, ADCYAP1R1 ALDH1A1 4176/4885LMNA 4267/4885ALOX15 3244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.